These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 32960454)

  • 1. Glucagon-like peptide 2 attenuates intestinal mucosal barrier injury through the MLCK/pMLC signaling pathway in a piglet model.
    Chang Y; Deng Q; Zhang Z; Zhao H; Tang J; Chen X; Liu G; Tian G; Cai J; Jia G
    J Cell Physiol; 2021 Apr; 236(4):3015-3032. PubMed ID: 32960454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury.
    Jin Y; Blikslager AT
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C996-C1004. PubMed ID: 27760753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated porcine glucagon-like peptide-2 improved the intestinal digestive function and prevented inflammation of weaning piglets challenged with LPS.
    Qi KK; Wu J; Deng B; Li YM; Xu ZW
    Animal; 2015 Sep; 9(9):1481-9. PubMed ID: 25963800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chang'an II Decoction ( II )-Containing Serum Ameliorates Tumor Necrosis Factor-α-Induced Intestinal Epithelial Barrier Dysfunction via MLCK-MLC Signaling Pathway in Rats.
    Chen T; Yin XL; Kang N; Wang XG; Li BS; Ji HJ; Zhang YQ; Bian LQ; Zhang BH; Wang FY; Tang XD
    Chin J Integr Med; 2020 Oct; 26(10):745-753. PubMed ID: 31768870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway.
    Cao M; Wang P; Sun C; He W; Wang F
    PLoS One; 2013; 8(5):e61944. PubMed ID: 23671580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chenodeoxycholic Acid (CDCA) Protects against the Lipopolysaccharide-Induced Impairment of the Intestinal Epithelial Barrier Function via the FXR-MLCK Pathway.
    Song M; Ye J; Zhang F; Su H; Yang X; He H; Liu F; Zhu X; Wang L; Gao P; Shu G; Jiang Q; Wang S
    J Agric Food Chem; 2019 Aug; 67(32):8868-8874. PubMed ID: 31319027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total polysaccharides of the Sijunzi decoction attenuate tumor necrosis factor-α-induced damage to the barrier function of a Caco-2 cell monolayer
    Lu Y; Li L; Zhang JW; Zhong XQ; Wei JA; Han L
    World J Gastroenterol; 2018 Jul; 24(26):2867-2877. PubMed ID: 30018481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prolonged effect of glucagon-like peptide 2 pretreatment on growth performance and intestinal development of weaned piglets.
    Deng QH; Jia G; Zhao H; Chen ZL; Chen XL; Liu GM; Wang KN
    J Anim Sci Biotechnol; 2016; 7():28. PubMed ID: 27148449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naringin attenuates MLC phosphorylation and NF-κB activation to protect sepsis-induced intestinal injury via RhoA/ROCK pathway.
    Li Z; Gao M; Yang B; Zhang H; Wang K; Liu Z; Xiao X; Yang M
    Biomed Pharmacother; 2018 Jul; 103():50-58. PubMed ID: 29635128
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Gao J; Cao S; Xiao H; Hu S; Yao K; Huang K; Jiang Z; Wang L
    Front Immunol; 2022; 13():897395. PubMed ID: 35911699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathelicidin-BF ameliorates lipopolysaccharide-induced intestinal epithelial barrier disruption in rat.
    Han F; Lu Z; Liu Y; Xia X; Zhang H; Wang X; Wang Y
    Life Sci; 2016 May; 152():199-209. PubMed ID: 27018068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenomedullin improves intestinal epithelial barrier function by downregulating myosin light chain phosphorylation in ulcerative colitis rats.
    Yi Z; Fan H; Liu X; Tang Q; Zuo D; Yang J
    Mol Med Rep; 2015 Sep; 12(3):3615-3620. PubMed ID: 26043783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.
    Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X
    Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrastigma hemsleyanum Diels et Gilg ameliorates lipopolysaccharide induced sepsis via repairing the intestinal mucosal barrier.
    Zhan L; Pu J; Zheng J; Hang S; Pang L; Dai M; Ji C
    Biomed Pharmacother; 2022 Apr; 148():112741. PubMed ID: 35217279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myosin light chain kinase mediates intestinal barrier disruption following burn injury.
    Chen C; Wang P; Su Q; Wang S; Wang F
    PLoS One; 2012; 7(4):e34946. PubMed ID: 22529961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine protects against burn-induced intestinal barrier injury via the MLCK/p-MLC signalling pathway.
    Qin C; Jiang Y; Chen X; Bian Y; Wang Y; Xie K; Yu Y
    Burns; 2021 Nov; 47(7):1576-1585. PubMed ID: 33933302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.
    Su L; Nalle SC; Shen L; Turner ES; Singh G; Breskin LA; Khramtsova EA; Khramtsova G; Tsai PY; Fu YX; Abraham C; Turner JR
    Gastroenterology; 2013 Aug; 145(2):407-15. PubMed ID: 23619146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total Flavonoid Extract from Hawthorn (Crataegus pinnatifida) Improves Inflammatory Cytokines-Evoked Epithelial Barrier Deficit.
    Liu F; Zhang X; Ji Y
    Med Sci Monit; 2020 Feb; 26():e920170. PubMed ID: 32065826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine glucagon-like peptide-2 microspheres ameliorate inflammation in lipopolysaccharide-challenged weaning piglets.
    Wu J; Qi KK; Xu ZW
    J Anim Sci; 2016 Dec; 94(12):5286-5294. PubMed ID: 28046174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebeccamycin Attenuates TNF-α-Induced Intestinal Epithelial Barrier Dysfunction by Inhibiting Myosin Light Chain Kinase Production.
    Watari A; Sakamoto Y; Hisaie K; Iwamoto K; Fueta M; Yagi K; Kondoh M
    Cell Physiol Biochem; 2017; 41(5):1924-1934. PubMed ID: 28391269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.